
Windtree Raises $520M for BNB Treasury Growth
Windtree Therapeutics’ Bold Leap: From Biotech to BNB Treasury Introduction: A Paradigm Shift in Corporate Strategy The intersection of biotechnology and cryptocurrency has rarely been more pronounced than in the case of Windtree Therapeutics. This publicly traded biotech firm, known for its focus on respiratory disease therapies, has made a dramatic pivot by announcing plans…